Neoadjuvant camrelizumab plus chemotherapy in resectable stage IIIA-IIIB non-small cell lung cancer: integrated multidimensional biomarker analysis from a phase II study.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42320986

Baiyang Huang; Chao Xie; Feifei Teng; Guoxin Cai; Haiyan Zhou; Hongfu Sun; Hui Jia; Jiarui Zhao; Jing Xu; Jingyu Zhu; Jinming Yu; Kaiyue Wang; Min Li; Pingping Song; Shuai Fu; Suzhen Wang; Wanhu Li; Xiao Han; Xingpeng Wang; Xue Meng; Zhendan Wang

Jun 20, 2026